{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:55:09Z","timestamp":1771617309993,"version":"3.50.1"},"reference-count":193,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>The occurrence of the diabetes happens due to the irregular operation of glucose in the body, which is also known as glucose homeostasis, thus leading to metabolic changes in the body. The two stages whether hypoglycemia or hyperglycemia differentiates diabetes into various categories and brought new innovative management for the new routes of administration of these disease condition. Various bio-nanotechnologies which are coupled with nano particulates, polymers, Liposome, various gold plated and Solid Lipids Particulates regulate the transcellular transport, non specific cellular uptake, and paracellular transport, which leads to oral, transdermal, Pulmonary, buccal, Nasal, specific gene oriented administration to avoid the non patience compliance with the parental routes of administration. Phytochemicals have an emerging strategy for the future prospects of diabetes management.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389557521666210623164052","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T13:35:02Z","timestamp":1624541702000},"page":"89-114","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nano-biotechnology and its Innovative Perspective in Diabetes Management"],"prefix":"10.2174","volume":"22","author":[{"given":"Jigar","family":"Raval","sequence":"first","affiliation":[{"name":"School of Pharmacy, National Forensic Sciences University, Gandhinagar 382007, Gujarat, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riddhi","family":"Trivedi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, National Forensic Sciences University, Gandhinagar 382007, Gujarat, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Suman","sequence":"additional","affiliation":[{"name":"CDSCO, Meghaninagar, Ahmedabad, Gujarat 380003, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Kukrety","sequence":"additional","affiliation":[{"name":"CDSCO, Meghaninagar, Ahmedabad, Gujarat 380003, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajesh","family":"Prajapati","sequence":"additional","affiliation":[{"name":"School of Pharmacy, National Forensic Sciences University, Gandhinagar 382007, Gujarat, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/adhm.201200037","volume":"1","author":"Bratlie K.M.","year":"2012","unstructured":"Bratlie K.M.; York R.L.; Invernale M.A.; Langer R.; Anderson D.G.; Materials for diabetes therapeutics. Adv Healthc Mater 2012,1(3),267-284","journal-title":"Adv Healthc Mater"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/smll.200801403","volume":"5","author":"Bahshi L.","year":"2009","unstructured":"Bahshi L.; Freeman R.; Gill R.; Willner I.; Optical detection of glucose by means of metal nanoparticles or semiconductor quantum dots. Small 2009,5(6),676-680","journal-title":"Small"},{"key":"ref=3","first-page":"84","author":"Chun A.","year":"2006","unstructured":"Chun A.; Nanosensors: Bring it on 2006,84","journal-title":"Nanosensors: Bring it on"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2174\/157341309789378069","volume":"5","author":"Nelson D.","year":"2009","unstructured":"Nelson D.; Priscyla D.; Zaine T.; Marcela D.; Fabio T.; Marcelo B.; State of the art of nanobiotechnology applications in neglected diseases. Curr Nanosci 2009,5(4),396-408","journal-title":"Curr Nanosci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.nano.2012.05.005","volume":"8","author":"Krol S.","year":"2012","unstructured":"Krol S.; Ellis-Behnke R.; Marchetti P.; Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments. Nanomedicine (Lond) 2012,8(Suppl. 1),S69-S76","journal-title":"Nanomedicine (Lond)"},{"key":"ref=6","first-page":"227","volume":"12","author":"Szablewski L.","year":"2011","unstructured":"Szablewski L.; Glucose Homeostasis \u2013 Mechanism and Defects. Diabetes \u2013 Damages and Treatments. Intechopen 2011,12,227-256","journal-title":"Intechopen"},{"key":"ref=7","year":"2008","unstructured":"Guidance for industry diabetes mellitus \u2014 evaluating cardiovascular risk in new antidia-betic therapies to treat type 2 diabetes. U.S. department of health and human services, food and drug administration, center for drug evaluation and research (CDER). 2008 https:\/\/www.federalregister.gov\/documents\/2008\/12\/19\/E8-30086\/guidance-for-industry-on-diabetes-mellitus-evaluating-cardiovascular-risk-in-new-antidiabetic"},{"key":"ref=8","author":"Yannis V.","year":"2020","unstructured":"Yannis V.; Trends of nanotechnology in type 2 diabetes mellitus treatment. Asian J Pharm Sci 2020","journal-title":"Asian J Pharm Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/wnan.1329","volume":"7","author":"DiSanto R.M.","year":"2015","unstructured":"DiSanto R.M.; Subramanian V.; Gu Z.; Recent advances in nanotechnology for diabetes treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2015,7(4),548-564","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc09-S062","volume":"32","year":"2009","unstructured":"Diagnosis and classification of diabetes mellitus, american diabetes association. Diabetes care 2009,32(Suppl. 1),S62-S67 https:\/\/care.diabetesjournals.org\/content\/32\/Supplement_1\/S62","journal-title":"Diabetes care"},{"key":"ref=11","first-page":"367","volume":"4","author":"Riaz S.","year":"2009","unstructured":"Riaz S.; Diabetes mellitus. Sci Res Essays 2009,4(5),367-373","journal-title":"Sci Res Essays"},{"key":"ref=12","unstructured":"Type 1 Diabetes Mellitus https:\/\/www.webmedcentral.com\/article_view\/36982008","journal-title":"Type 1 Diabetes Mellitus"},{"key":"ref=13","author":"Luke R.","year":"2020","unstructured":"Luke R.; Devleena D.; Natalia H.; Raghavendra G.; Daniel G.; Nanomedicine-based strategies for diabetes: Diagnostics, monitoring, a 2020","journal-title":"Nanomedicine-based strategies for diabetes: Diagnostics, monitoring, a"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/14746514070070010301","volume":"7","author":"Gupta R.","year":"2007","unstructured":"Gupta R.; Mishra A.; Type 2 diabetes in India: Regional disparities. Br J Diabetes Vasc 2007,7(1),12-16","journal-title":"Br J Diabetes Vasc"},{"key":"ref=15","first-page":"787","year":"2004","unstructured":"Pathogenesis of type 2 diabetes mellitus. Med Clin N 2004,787-835","journal-title":"Med Clin N"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrm2391","volume":"9","author":"Guilherme A.","year":"2008","unstructured":"Guilherme A.; Virbasius J.V.; Puri V.; Czech M.P.; Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008,9(5),367-377","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1900\/RDS.2007.4.13","volume":"4","author":"Dedoussis G.V.","year":"2007","unstructured":"Dedoussis G.V.; Kaliora A.C.; Panagiotakos D.B.; Genes, diet and type 2 diabetes mellitus: A review. Rev Diabet Stud 2007,4(1),13-24","journal-title":"Rev Diabet Stud"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1600-0757.2006.00193.x","volume":"44","author":"Mealey B.L.","year":"2007","unstructured":"Mealey B.L.; Ocampo G.L.; Gloria L.; Diabetes mellitus and periodontal disease. Periodontol 2000 2007,44,127-153","journal-title":"Periodontol 2000"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/qjmed\/hch077","volume":"97","author":"Younis N.","year":"2004","unstructured":"Younis N.; Soran H.; Farook S.; The prevention of type 2 diabetes mellitus: recent advances. QJM 2004,97(7),451-455","journal-title":"QJM"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.snb.2012.04.016","volume":"168","author":"Leea S.","year":"2012","unstructured":"Leea S.; Parka J.; Kima I.; Younb B.; Gua M.; Sensitive detection of adipokines for early diagnosis of type 2 diabetes using enzyme-linked antibody-aptamer sandwich (ELAAS) assays. Sens Actuators B Chem 2012,168,243-248","journal-title":"Sens Actuators B Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1758-5996-2-66","volume":"2","author":"Kalra S.","year":"2010","unstructured":"Kalra S.; Kalra B.; Agrawal N.; Oral insulin. Diabetol Metab Syndr 2010,2,66","journal-title":"Diabetol Metab Syndr"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/193229680900300323","volume":"3","author":"Heinemann L.","year":"2009","unstructured":"Heinemann L.; Jacques Y.; Oral insulin and buccal insulin: a critical reappraisal. J Diabetes Sci Technol 2009,3(3),568-584","journal-title":"J Diabetes Sci Technol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/193229680900300322","volume":"3","author":"Arbit E.","year":"2009","unstructured":"Arbit E.; Kidron M.; Oral insulin: the rationale for this approach and current developments. J Diabetes Sci Technol 2009,3(3),562-567","journal-title":"J Diabetes Sci Technol"},{"key":"ref=24","volume":"6","year":"2004","unstructured":"Ehud arbit the physiological rationale for oral insulin administration. Diabetes Technol Ther 2004,6(4)","journal-title":"Diabetes Technol Ther"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","volume":"32","author":"Chen M.C.","year":"2011","unstructured":"Chen M.C.; Sonaje K.; Chen K.J.; Sung H.W.; A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomaterials 2011,32(36),9826-9838","journal-title":"Biomaterials"},{"key":"ref=26","author":"Amani M.","year":"2012","unstructured":"Amani M.; Oral Delivery of Insulin: Novel Approaches, Recent Advances in Novel Drug Carrier Systems 2012","journal-title":"Oral Delivery of Insulin: Novel Approaches, Recent Advances in Novel Drug Carrier Systems"},{"key":"ref=27","first-page":"S4","author":"Ahmad A.","year":"2012","unstructured":"Ahmad A.; Oral nano-insulin therapy: Current progress on nanoparticle-based devices for intestinal epithelium-targeted insulin delivery J Nanomedic Nanotechnol 2012,S4","journal-title":"J Nanomedic Nanotechnol"},{"key":"ref=28","first-page":"7","volume":"4","author":"Vinod K.","year":"2012","unstructured":"Vinod K.; Reddy R.; Critical review on mucoadhesive drug delivery system. JD Med 2012,4(1),7-28","journal-title":"JD Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","volume":"61","author":"Lai S.K.","year":"2009","unstructured":"Lai S.K.; Wang Y.Y.; Hanes J.; Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 2009,61(2),158-171","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrmicro1840","volume":"6","author":"Wells J.M.","year":"2008","unstructured":"Wells J.M.; Mercenier A.; Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 2008,6(5),349-362","journal-title":"Nat Rev Microbiol"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-10-5","author":"Azizi F.","year":"2009","unstructured":"Azizi F.; Ghanbarian A.; Momenan A. A.; Prevention of noncommunicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II 2009","journal-title":"Tehran lipid and glucose study phase II"},{"key":"ref=32","first-page":"1","volume":"04","year":"2014","unstructured":"Diabetes mellitus \u2013 a devastating metabolic disorder. Asian J.bio","journal-title":"Pharm Sci"},{"key":"ref=33","first-page":"5","volume":"62","author":"Lebovitz H.E.","year":"2001","unstructured":"Lebovitz H.E.; Diagnosis, classification, and pathogenesis of diabetes mellitus. J Clin Psychiatry 2001,62(27)(Suppl. 27),5-9","journal-title":"J Clin Psychiatry"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22159\/ijcpr.2017v9i1.16615","volume":"9","author":"Muhas Chelakkadan Naseef P.P.","year":"2016","unstructured":"Muhas Chelakkadan Naseef P.P.; A review article-gestational diabetes mellitus. Int J Curr Pharm Res 2016,9(1),1","journal-title":"Int J Curr Pharm Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.2174\/1381612811319270013","volume":"19","author":"Papanas N.","year":"2013","unstructured":"Papanas N.; Katsiki N.; Putz Z.; Mikhailidis D.P.; Diabetes, obesity and vascular disease-an update. Curr Pharm Des 2013,19(27),4900-4903","journal-title":"Curr Pharm Des"},{"key":"ref=36","doi-asserted-by":"publisher","DOI":"10.1080\/02652040500273753","author":"Budhian A.","year":"2004","unstructured":"Budhian A.; Winey K.; Siegel S.; Production of haloperidol loaded PLGA nanoparticles for extended controlled drug release of haloperi-dol. 2004 https:\/\/repository.upenn.edu\/cgi\/viewcontent.cgi?referer=https:\/\/www.google.com\/"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.progpolymsci.2012.04.004","volume":"37","author":"Mukhopadhyaya P.","year":"2012","unstructured":"Mukhopadhyaya P.; Mishrab R.; Ranac D.; Patit P.; Kundua P.P.; Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review. Prog Polym Sci 2012,37,1457-1475","journal-title":"Prog Polym Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-5173(02)00486-6","volume":"249","author":"Pan Y.","year":"2002","unstructured":"Pan Y.; Li Y.J.; Zhao H.Y.; Zheng J.M.; Xu H.; Wei G.; Hao J.S.; Cui F.D.; Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 2002,249(1-2),139-147","journal-title":"Int J Pharm"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/jps.20520","volume":"95","author":"Mao S.","year":"2006","unstructured":"Mao S.; Bakowsky U.; Jintapattanakit A.; Kissel T.; Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J Pharm Sci 2006,95(5),1035-1048","journal-title":"J Pharm Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jconrel.2008.08.020","volume":"132","author":"Lin Y.H.","year":"2008","unstructured":"Lin Y.H.; Sonaje K.; Lin K.M.; Juang J.H.; Mi F.L.; Yang H.W.; Sung H.W.; Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J Control Release 2008,132(2),141-149","journal-title":"J Control Release"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1021\/bc800076n","volume":"19","author":"Mi F.L.","year":"2008","unstructured":"Mi F.L.; Wu Y.Y.; Lin Y.H.; Sonaje K.; Ho Y.C.; Chen C.T.; Juang J.H.; Sung H.W.; Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation. Bioconjug Chem 2008,19(6),1248-1255","journal-title":"Bioconjug Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nano.2008.01.003","volume":"4","author":"Bayat A.","year":"2008","unstructured":"Bayat A.; Larijani B.; Ahmadian S.; Junginger H.E.; Rafiee-Tehrani M.; Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives. Nanomedicine (Lond) 2008,4(2),115-120","journal-title":"Nanomedicine (Lond)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1208\/s12249-010-9561-2","volume":"12","author":"Chaudhury A.","year":"2011","unstructured":"Chaudhury A.; Das S.; Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS PharmSciTech 2011,12(1),10-20","journal-title":"AAPS PharmSciTech"},{"key":"ref=44","author":"Assal M.","year":"2008","unstructured":"Assal M.; Peroral insulin delivery: New concepts and excipients 2008","journal-title":"Peroral insulin delivery: New concepts and excipients"},{"key":"ref=45","first-page":"198","volume":"18","author":"Kumar T.","year":"2005","unstructured":"Kumar T.; Paul W.; Sharma C.; Kuriachan M.; Bioadhesive, pH responsive micromatrix for oral delivery of insulin. Trends Biomater Artif Organs 2005,18,198-202","journal-title":"Trends Biomater Artif Organs"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jconrel.2009.01.011","volume":"135","author":"Rekha M.R.","year":"2009","unstructured":"Rekha M.R.; Sharma C.P.; Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. J Control Release 2009,135(2),144-151","journal-title":"J Control Release"},{"key":"ref=47","author":"Kydonieus A.","year":"2008","unstructured":"Kydonieus A.; Elson C.; Thanou M.; Methods of drug delivery using sulphated chitinous polymers. 2008"},{"key":"ref=48","author":"Sharma C.","year":"2007","unstructured":"Sharma C.; Mannemcherril R.; Opinion on Therapeutic Patents 2007","journal-title":"Opinion on Therapeutic Patents"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2174\/187221109787158346","volume":"3","author":"Wong T.W.","year":"2009","unstructured":"Wong T.W.; Chitosan and its use in design of insulin delivery system. Recent Pat Drug Deliv Formul 2009,3(1),8-25","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/mabi.200900223","volume":"10","author":"Shofner J.P.","year":"2010","unstructured":"Shofner J.P.; Phillips M.A.; Peppas N.A.; Cellular evaluation of synthesized insulin\/transferrin bioconjugates for oral insulin delivery using intelligent complexation hydrogels. Macromol Biosci 2010,10(3),299-306","journal-title":"Macromol Biosci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.carbpol.2010.10.070","volume":"84","author":"Sonia T.","year":"2011","unstructured":"Sonia T.; Sharma C.; In vitro evaluation of N-(2-hydroxy) propyl-3 trimethyl ammonium chitosan for oral insulin delivery. Carbohydr Polym 2011,84(1),103-109","journal-title":"Carbohydr Polym"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1208\/s12249-011-9716-9","volume":"12","author":"Mahjub R.","year":"2011","unstructured":"Mahjub R.; Dorkoosh F.A.; Amini M.; Khoshayand M.R.; Rafiee-Tehrani M.; Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan. AAPS PharmSciTech 2011,12(4),1407-1419","journal-title":"AAPS PharmSciTech"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","volume":"33","author":"Su F.Y.","year":"2012","unstructured":"Su F.Y.; Lin K.J.; Sonaje K.; Wey S.P.; Yen T.C.; Ho Y.C.; Panda N.; Chuang E.Y.; Maiti B.; Sung H.W.; Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Biomaterials 2012,33(9),2801-2811","journal-title":"Biomaterials"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.progpolymsci.2011.06.003","volume":"37","author":"Lee K.Y.","year":"2012","unstructured":"Lee K.Y.; Mooney D.J.; Alginate: properties and biomedical applications. Prog Polym Sci 2012,37(1),106-126","journal-title":"Prog Polym Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"9040","DOI":"10.1016\/j.biomaterials.2010.07.111","volume":"31","author":"Chan A.W.","year":"2010","unstructured":"Chan A.W.; Neufeld R.J.; Tuneable semi-synthetic network alginate for absorptive encapsulation and controlled release of protein therapeutics. Biomaterials 2010,31(34),9040-9047","journal-title":"Biomaterials"},{"key":"ref=56","first-page":"1","volume":"7","author":"Mahkam M.","year":"2009","unstructured":"Mahkam M.; Modification of nano alginate-chitosan matrix for oral delivery of insulin. Nat Sci 2009,7(8),1-7","journal-title":"Nat Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ijpharm.2010.04.006","volume":"393","author":"Zhang N.","year":"2010","unstructured":"Zhang N.; Li J.; Jiang W.; Ren C.; Li J.; Xin J.; Li K.; Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate\/chitosan nanoparticles. Int J Pharm 2010,393(1-2),212-218","journal-title":"Int J Pharm"},{"key":"ref=58","first-page":"12","volume":"15","author":"Narayani R.","year":"2001","unstructured":"Narayani R.; Oral delivery of insulin needles needless. Trends Biomater Artif Organs 2001,15(1),12-16","journal-title":"Trends Biomater Artif Organs"},{"key":"ref=59","first-page":"277","volume":"1","author":"Tyagi C.","year":"2012","unstructured":"Tyagi C.; Tomar L.; pH responsive polymeric nanoparticles for oral insulin delivery. Int J Appl Pharm [IJPPT].2012,1(2),277-3436","journal-title":"Int J Appl Pharm"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jconrel.2006.05.013","volume":"114","author":"Cui F.","year":"2006","unstructured":"Cui F.; Shi K.; Zhang L.; Tao A.; Kawashima Y.; Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release 2006,114(2),242-250","journal-title":"J Control Release"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/0883911507088276","volume":"23","author":"Davaran S.","year":"2008","unstructured":"Davaran S.; Omidi Y.; Rashidi M.R.; Anzabi M.; Shayanfar A.; Preparation and in vitro evaluation of linear and star-branched PLGA nanoparticles for insulin delivery. J Bioact Compat Polym 2008,23,115-131","journal-title":"J Bioact Compat Polym"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.12.055","volume":"425","author":"Wu Z.M.","year":"2012","unstructured":"Wu Z.M.; Zhou L.; Guo X.D.; Jiang W.; Ling L.; Qian Y.; Luo K.Q.; Zhang L.J.; HP55-coated capsule containing PLGA\/RS nanoparticles for oral delivery of insulin. Int J Pharm 2012,425(1-2),1-8","journal-title":"Int J Pharm"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijpharm.2011.12.038","volume":"440","author":"Sharma G.","year":"2013","unstructured":"Sharma G.; van der Walle C.F.; Ravi Kumar M.N.; Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics. Int J Pharm 2013,440(1),99-110","journal-title":"Int J Pharm"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1124\/jpet.109.158147","volume":"333","author":"Price T.O.","year":"2010","unstructured":"Price T.O.; Farr S.A.; Yi X.; Vinogradov S.; Batrakova E.; Banks W.A.; Kabanov A.V.; Transport across the blood-brain barrier of pluronic leptin. J Pharmacol Exp Ther 2010,333(1),253-263","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","volume":"130","author":"Batrakova E.V.","year":"2008","unstructured":"Batrakova E.V.; Kabanov A.V.; Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008,130(2),98-106","journal-title":"J Control Release"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2007.04.004","volume":"120","author":"Xiong X.Y.","year":"2007","unstructured":"Xiong X.Y.; Li Y.P.; Li Z.L.; Zhou C.L.; Tam K.C.; Liu Z.Y.; Xie G.X.; Vesicles from Pluronic\/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. J Control Release 2007,120(1-2),11-17","journal-title":"J Control Release"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.colsurfb.2012.07.005","volume":"101","author":"Barwal I.","year":"2013","unstructured":"Barwal I.; Sood A.; Sharma M.; Singh B.; Yadav S.C.; Development of stevioside Pluronic-F-68 copolymer based PLA-nanoparticles as an antidiabetic nanomedicine. Colloids Surf B Biointerfaces 2013,101,510-516","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jconrel.2007.05.019","volume":"122","author":"Chalasani K.B.","year":"2007","unstructured":"Chalasani K.B.; Russell-Jones G.J.; Jain A.K.; Diwan P.V.; Jain S.K.; Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J Control Release 2007,122(2),141-150","journal-title":"J Control Release"},{"key":"ref=69","author":"Zion T.C.","year":"2003","unstructured":"Zion T.C.; Glucose-sensitive nanoparticles for controlled insulin delivery; Department of chemical engineering 2003"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1016\/j.biomaterials.2008.06.019","volume":"29","author":"Higashi T.","year":"2008","unstructured":"Higashi T.; Hirayama F.; Misumi S.; Arima H.; Uekama K.; Design and evaluation of polypseudorotaxanes of pegylated insulin with cyclodextrins as sustained release system. Biomaterials 2008,29(28),3866-3871","journal-title":"Biomaterials"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0939-6411(03)00145-0","volume":"57","author":"Foss A.C.","year":"2004","unstructured":"Foss A.C.; Goto T.; Morishita M.; Peppas N.A.; Development of acrylic-based copolymers for oral insulin delivery. Eur J Pharm Biopharm 2004,57(2),163-169","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijpharm.2006.05.050","volume":"323","author":"Kumar A.","year":"2006","unstructured":"Kumar A.; Lahiri S.S.; Singh H.; Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery. Int J Pharm 2006,323(1-2),117-124","journal-title":"Int J Pharm"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1016\/j.actbio.2010.02.007","volume":"6","author":"Sajeesh S.","year":"2010","unstructured":"Sajeesh S.; Vauthier C.; Gueutin C.; Ponchel G.; Sharma C.P.; Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery. Acta Biomater 2010,6(8),3072-3080","journal-title":"Acta Biomater"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1023\/A:1007696723125","volume":"17","author":"Michaela K.","year":"2000","unstructured":"Michaela K.; Oral Delivery System for Insulin. Pharmaceutical Research. Pharm Res 2000,17(12),1468-1474","journal-title":"Pharm Res"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jbm.a.32490","volume":"92","author":"Mahkam M.","year":"2010","unstructured":"Mahkam M.; Starch-based polymeric carriers for oral-insulin delivery. J Biomed Mater Res A 2010,92(4),1392-1397","journal-title":"J Biomed Mater Res A"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.2337\/dci18-0023","volume":"41","author":"Jane L.","year":"2018","unstructured":"Jane L.; David M.; Katharine C.; Korey K.; Lori M.; Stuart A.; Joseph I.; Desmond S.; Diabetes Care 2018,41(9),2026-2044","journal-title":"Diabetes Care"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jconrel.2006.10.023","volume":"117","author":"Damg&#xE9; C.","year":"2007","unstructured":"Damg&#xE9; C.; Maincent P.; Ubrich N.; Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release 2007,117(2),163-170","journal-title":"J Control Release"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0168-3659(99)00247-3","volume":"65","author":"Carino G.P.","year":"2000","unstructured":"Carino G.P.; Jacob J.S.; Mathiowitz E.; Nanosphere based oral insulin delivery. J Control Release 2000,65(1-2),261-269","journal-title":"J Control Release"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.addr.2009.10.004","volume":"62","author":"Kope&#x10D;ek J.","year":"2010","unstructured":"Kope&#x10D;ek J.; Kopeckov&#xE1; P.; HPMA copolymers: origins, early developments, present, and future. Adv Drug Deliv Rev 2010,62(2),122-149","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=80","first-page":"46","author":"Oman M.","year":"2005","unstructured":"Oman M.; Liu J.; Chen J.; Durrant D.; Yang H.S.; He Y.; Kopeckov&#xE1; P.; Using N-(2-hydroxypropyl) methacrylamide copolymer drug bioconjugate as a novel approach to deliver a Bcl-2-targeting compound HA14-1 in vivo. Proc Am Assoc Cancer Res 2005,46","journal-title":"Proc Am Assoc Cancer Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejps.2010.12.007","volume":"42","author":"Makhlof A.","year":"2011","unstructured":"Makhlof A.; Tozuka Y.; Takeuchi H.; Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 2011,42(5),445-451","journal-title":"Eur J Pharm Sci"},{"key":"ref=82","first-page":"281","unstructured":"Elsayed, AM Oral Delivery of Insulin: Novel Approaches Recent Advances in Novel Drug Carrier Systems ,281-314","journal-title":"Elsayed, AM Oral Delivery of Insulin: Novel Approaches Recent Advances in Novel Drug Carrier Systems"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1002\/anie.200900441","volume":"48","author":"Kabanov A.V.","year":"2009","unstructured":"Kabanov A.V.; Vinogradov S.V.; Nanogels as pharmaceutical carriers: Finite networks of infinite capabilities. Angew Chem Int Ed Engl 2009,48(30),5418-5429","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=84","volume":"20","author":"Rekha M.R.","year":"2007","unstructured":"Rekha M.R.; Pullulan as a promising biomaterial for biomedical applications: A perspective. Trends Biomater Artif Organs 2007,20(2)","journal-title":"Trends Biomater Artif Organs"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1016\/j.biomaterials.2003.09.065","volume":"25","author":"Lee I.","year":"2004","unstructured":"Lee I.; Akiyoshi K.; Single molecular mechanics of a cholesterol-bearing pullulan nanogel at the hydrophobic interfaces. Biomaterials 2004,25(15),2911-2918","journal-title":"Biomaterials"},{"key":"ref=86","first-page":"71","author":"Torchilin VP","year":"2008","unstructured":"Torchilin VP; Chemical modification of nanogels for targeted delivery. Multifunctional pharmaceutical nanocarrires 2008,71-75","journal-title":"Multifunctional pharmaceutical nanocarrires"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carbpol.2013.02.021","volume":"95","author":"Minimol P.F.","year":"2013","unstructured":"Minimol P.F.; Paul W.; Sharma C.P.; PEGylated starch acetate nanoparticles and its potential use for oral insulin delivery. Carbohydr Polym 2013,95(1),1-8","journal-title":"Carbohydr Polym"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2337\/diab.37.2.246","volume":"37","author":"Damg&#xE9; C.","year":"1988","unstructured":"Damg&#xE9; C.; Michel C.; Aprahamian M.; Couvreur P.; New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 1988,37(2),246-251","journal-title":"Diabetes"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/(SICI)1097-4636(19991215)47:4<568::AID-JBM14>3.0.CO;2-X","volume":"47","author":"Aboubakar M.","year":"1999","unstructured":"Aboubakar M.; Puisieux F.; Couvreur P.; Deyme M.; Vauthier C.; Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. J Biomed Mater Res 1999,47(4),568-576","journal-title":"J Biomed Mater Res"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1021\/js970124i","volume":"86","author":"Damg&#xE9; C.","year":"1997","unstructured":"Damg&#xE9; C.; Vranckx H.; Balschmidt P.; Couvreur P.; Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. J Pharm Sci 1997,86(12),1403-1409","journal-title":"J Pharm Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1023\/A:1007574030674","volume":"17","author":"Watnasirichaikul S.","year":"2000","unstructured":"Watnasirichaikul S.; Davies N.M.; Rades T.; Tucker I.G.; Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharm Res 2000,17(6),684-689","journal-title":"Pharm Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ejps.2008.01.013","volume":"33","author":"Graf A.","year":"2008","unstructured":"Graf A.; Jack K.S.; Whittaker A.K.; Hook S.M.; Rades T.; Protein delivery using nanoparticles based on microemulsions with different structure-types. Eur J Pharm Sci 2008,33(4-5),434-444","journal-title":"Eur J Pharm Sci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejps.2008.12.017","volume":"37","author":"Graf A.","year":"2009","unstructured":"Graf A.; Rades T.; Hook S.M.; Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimisation and in vivo evaluation. Eur J Pharm Sci 2009,37(1),53-61","journal-title":"Eur J Pharm Sci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijpharm.2007.08.053","volume":"350","author":"Graf A.","year":"2008","unstructured":"Graf A.; Ablinger E.; Peters S.; Zimmer A.; Hook S.; Rades T.; Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides. Int J Pharm 2008,350(1-2),351-360","journal-title":"Int J Pharm"},{"key":"ref=95","author":"Stacia F.","year":"1995","unstructured":"Stacia F.; Fabrication and Characterization of an oral Insulin Delivery System Utilizing Poly (Fumaric- Co- Sebacic Anhydride). Microspheres by Stacia Furtado ScB Brown University [A Dissertation submitted in Partial Fulfillment of the requirements for the degree of doctor of philosophy in the division of biology and medicine at Brown University].1995","journal-title":"Microspheres by Stacia Furtado ScB Brown University"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/1520-6017(200010)89:10<1253::AIDJPS3>3.0.CO;2-8","volume":"89","author":"Clausen A.E.","year":"2000","unstructured":"Clausen A.E.; Bernkop-Schn&#xFC;rch A.; In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J Pharm Sci 2000,89(10),1253-1261","journal-title":"J Pharm Sci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1023\/A:1007696723125","volume":"17","author":"Marsch&#xFC;tz M.K.","year":"2000","unstructured":"Marsch&#xFC;tz M.K.; Caliceti P.; Bernkop-Schn&#xFC;rch A.; Design and in vivo evaluation of an oral delivery system for insulin. Pharm Res 2000,17(12),1468-1474","journal-title":"Pharm Res"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejps.2004.03.015","volume":"22","author":"Calceti P.","year":"2004","unstructured":"Calceti P.; Salmaso S.; Walker G.; Bernkop-Schn&#xFC;rch A.; Bernkop-Schn&#xFC;rch A.; Development and in vivo evaluation of an oral insulin-PEG delivery system. Eur J Pharm Sci 2004,22(4),315-323","journal-title":"Eur J Pharm Sci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrd1632","volume":"4","author":"Torchilin V.P.","year":"2005","unstructured":"Torchilin V.P.; Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005,4(2),145-160","journal-title":"Nat Rev Drug Discov"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2217\/nnm.11.116","volume":"6","author":"Niu M.","year":"2011","unstructured":"Niu M.; Lu Y.; Hovgaard L.; Wu W.; Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Int J Nanomedicine 2011,6,1155-1166","journal-title":"Int J Nanomedicine"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2337\/diacare.13.9.911","volume":"13","author":"Spangler R.S.","year":"1990","unstructured":"Spangler R.S.; Insulin administration via liposomes. Diabetes Care 1990,13(9),911-922","journal-title":"Diabetes Care"},{"key":"ref=102","year":"2003","unstructured":"Liposomes for Drug Delivery 2003","journal-title":"Liposomes for Drug Delivery"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2217\/17435889.1.3.297","volume":"1","author":"Immordino M.L.","year":"2006","unstructured":"Immordino M.L.; Dosio F.; Cattel L.; Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006,1(3),297-315","journal-title":"Int J Nanomedicine"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0378-5173(98)00408-6","volume":"180","author":"Kim A.","year":"1999","unstructured":"Kim A.; Yun M.O.; Oh Y.K.; Ahn W.S.; Kim C.K.; Pharmacodynamics of insulin in polyethylene glycol-coated liposomes. Int J Pharm 1999,180(1),75-81","journal-title":"Int J Pharm"},{"key":"ref=105","first-page":"4","volume":"87","author":"Shaw J.E.","year":"2010","unstructured":"Shaw J.E.; Sicree R.A.; Zimmet P.Z.; Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes research and clinical practise. 2010,87(1),4-14"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijpharm.2005.01.018","volume":"294","author":"Zhang N.","year":"2005","unstructured":"Zhang N.; Ping Q.N.; Huang G.H.; Xu W.F.; Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm 2005,294(1-2),247-259","journal-title":"Int J Pharm"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.2147\/IJN.S38043","volume":"7","author":"Li C.","year":"2012","unstructured":"Li C.; Zhang Y.; Su T.; Feng L.; Long Y.; Chen Z.; Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin. Int J Nanomedicine 2012,7,5995-6002","journal-title":"Int J Nanomedicine"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/10611860701453653","volume":"15","author":"Jain A.K.","year":"2007","unstructured":"Jain A.K.; Chalasani K.B.; Khar R.K.; Ahmed F.J.; Diwan P.V.; Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery. J Drug Target 2007,15(6),417-427","journal-title":"J Drug Target"},{"key":"ref=109","first-page":"595","volume":"2","author":"Martins S.","year":"2007","unstructured":"Martins S.; Sarmento B.; Ferreira D.C.; Souto E.B.; Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles. Int J Nanomedicine 2007,2(4),595-607","journal-title":"Int J Nanomedicine"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0378-5173(94)90214-3","volume":"101","author":"Kook K.C.","year":"1994","unstructured":"Kook K.C.; Eun-Bin I.; Soo-Jeong L.; Yu-Kyoung O.; Seok-Kyu H.; Development of glucose-triggered pH-sensitive liposomes for a potential insulin delivery. Int J Pharm 1994,101(3),191-197","journal-title":"Int J Pharm"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1021\/js980235x","volume":"88","author":"Iwanaga K.","year":"1999","unstructured":"Iwanaga K.; Ono S.; Narioka K.; Kakemi M.; Morimoto K.; Yamashita S.; Namba Y.; Oku N.; Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome\u2019s surface on the GI transit of insulin. J Pharm Sci 1999,88(2),248-252","journal-title":"J Pharm Sci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ijpharm.2011.05.061","volume":"415","author":"Park S.J.","year":"2011","unstructured":"Park S.J.; Choi S.G.; Davaa E.; Park J.S.; Encapsulation enhancement and stabilization of insulin in cationic liposomes. Int J Pharm 2011,415(1-2),267-272","journal-title":"Int J Pharm"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1081\/DDC-100101255","volume":"26","author":"Cherian A.K.","year":"2000","unstructured":"Cherian A.K.; Rana A.C.; Jain S.K.; Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Dev Ind Pharm 2000,26(4),459-463","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.procbio.2012.01.018","volume":"47","author":"Paul W.","year":"2012","unstructured":"Paul W.; Sharma C.P.; Synthesis and characterization of alginate coated zinc calcium phosphate nanoparticles for intestinal delivery of insulin. Process Biochem 2012,47(5),882-886","journal-title":"Process Biochem"},{"key":"ref=115","first-page":"37","volume":"14","author":"Paul W.","year":"2001","unstructured":"Paul W.; Sharma C.P.; Porous hydroxyapatite nanoparticles for intestinal delivery of insulin. Trends Biomater Artif Organs 2001,14,37-38","journal-title":"Trends Biomater Artif Organs"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.addr.2011.08.006","volume":"64","author":"Rana S.","year":"2012","unstructured":"Rana S.; Bajaj A.; Mout R.; Rotello V.M.; Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev 2012,64(2),200-216","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","volume":"24","author":"Bhumkar D.R.","year":"2007","unstructured":"Bhumkar D.R.; Joshi H.M.; Sastry M.; Pokharkar V.B.; Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res 2007,24(8),1415-1426","journal-title":"Pharm Res"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2147\/IJN.S26650","volume":"7","author":"Daisy P.","year":"2012","unstructured":"Daisy P.; Saipriya K.; Biochemical analysis of Cassia fistula aqueous extract and phytochemically synthesized gold nanoparticles as hypoglycemic treatment for diabetes mellitus. Int J Nanomedicine 2012,7,1189-1202","journal-title":"Int J Nanomedicine"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.surg.2010.05.013","volume":"148","author":"Rink J.S.","year":"2010","unstructured":"Rink J.S.; McMahon K.M.; Chen X.; Mirkin C.A.; Thaxton C.S.; Kaufman D.B.; Dixon B.; Kaufman D.B.; Transfection of pancreatic islets using polyvalent DNA-functionalized gold nanoparticles. Surgery 2010,148(2),335-345","journal-title":"Surgery"},{"key":"ref=120","first-page":"80","year":"2012","unstructured":"Ekambaram, PA solid lipid nanoparticles: A review. Department of pharmaceutics Sci. Revs. Chem Commun 2012,80-102","journal-title":"Chem Commun"},{"key":"ref=121","first-page":"508","author":"Pedro F.","year":"2012","unstructured":"Pedro F.; Fernanda A.; Francisca A.; Cl&#xE1;udia, A.; Jose, N.; Bruno, S. Chitosan-Coated Solid Lipid Nanoparticles for Insulin Delivery. Methods Enzymol 2012,508","journal-title":"Methods Enzymol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.07.026","volume":"327","author":"Zhang N.","year":"2006","unstructured":"Zhang N.; Ping Q.; Huang G.; Xu W.; Cheng Y.; Han X.; Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm 2006,327(1-2),153-159","journal-title":"Int J Pharm"},{"key":"ref=123","first-page":"3333","volume":"7","author":"Zhang Z.H.","year":"2012","unstructured":"Zhang Z.H.; Zhang Y.L.; Zhou J.P.; Lv H.X.; Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin. Int J Nanomedicine 2012,7,3333-3339","journal-title":"Int J Nanomedicine"},{"key":"ref=124","first-page":"743","volume":"2","author":"Sarmento B.","year":"2007","unstructured":"Sarmento B.; Martins S.; Ferreira D.; Souto E.B.; Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomedicine 2007,2(4),743-749","journal-title":"Int J Nanomedicine"},{"key":"ref=125","first-page":"976","author":"Shukla Jill B.","year":"2010","unstructured":"Shukla Jill B.; Koli A.; Ranch Ketan M.; Parikh Rajesh, K Self Mirco Emulsifying Drug Delivery System 2010,976","journal-title":"Parikh Rajesh, K Self Mirco Emulsifying Drug Delivery System"},{"key":"ref=126","first-page":"2","author":"Xiaoyang L.","year":"2012","unstructured":"Xiaoyang L.; Jianping Q.; Yunchang X.; Xi Z.; Shunwen H.; Ying X.; Yi L.; Wei W.; Nanoemulsions coated with alginate\/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats 2012,2","journal-title":"Nanoemulsions coated with alginate\/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ejps.2006.12.007","volume":"30","author":"Reis C.P.","year":"2007","unstructured":"Reis C.P.; Ribeiro A.J.; Houng S.; Veiga F.; Neufeld R.J.; Nanoparticulate delivery system for insulin: design, characterization and in vitro\/in vivo bioactivity. Eur J Pharm Sci 2007,30(5),392-397","journal-title":"Eur J Pharm Sci"},{"key":"ref=128","first-page":"776","volume":"9","author":"Rayanta P.","year":"2013","unstructured":"Rayanta P.; Geeta N.; Ashutosh M.; Yogesh B.; Bhushan M.; Arvind K.; Shyam S.; SNEDDS curcumin formulation leads to enhanced protection from pain and functional associated with diabetic neuropathy:An insight into its mechanism for neuroprotection, Nanomedicine: Nanotechnology. Biol Med (Aligarh) 2013,9(6),776-785","journal-title":"Biol Med (Aligarh)"},{"key":"ref=129","first-page":"3405","volume":"6","author":"Zhang J.","year":"2011","unstructured":"Zhang J.; Peng Q.; Shi S.; Zhang Q.; Sun X.; Gong T.; Zhang Z.; Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex. Int J Nanomedicine 2011,6,3405-3414","journal-title":"Int J Nanomedicine"},{"key":"ref=130","first-page":"79","volume":"77","author":"Starokadomski&#x12D; P.L.","year":"2005","unstructured":"Starokadomski&#x12D; P.L.; Dube&#x12D; I.Ia.; [Lysalbinic acid--a new absorption enhancer for the buccal delivery of peptide drugs]. Ukr Biokhim Zh (1999) 2005,77(6),79-85","journal-title":"Ukr Biokhim Zh (1999)"},{"key":"ref=131","first-page":"1","volume":"2","author":"Kumria R.","year":"2011","unstructured":"Kumria R.; Goomber G.; Emerging trends in insulin delivery: Buccal route. J Diabetes 2011,2,1","journal-title":"J Diabetes"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1002\/dmrr.208","volume":"18","author":"Modi P.","year":"2002","unstructured":"Modi P.; Mihic M.; Lewin A.; The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist System. Diabetes Metab Res Rev 2002,18(1)(Suppl. 1),S38-S42","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0378-5173(89)90316-5","volume":"53","author":"Aungst B.","year":"1989","unstructured":"Aungst B.; Rogers N.; Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int J Pharm 1989,53,227-235","journal-title":"Int J Pharm"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1517\/17425247.5.9.1047","volume":"5","author":"Bernstein G.","year":"2008","unstructured":"Bernstein G.; Delivery of insulin to the buccal mucosa utilizing the RapidMist system. Expert Opin Drug Deliv 2008,5(9),1047-1055","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=135","first-page":"217","volume":"56","author":"Venugopalan P.","year":"2001","unstructured":"Venugopalan P.; Sapre A.; Venkatesan N.; Vyas S.P.; Pelleted bioadhesive polymeric nanoparticles for buccal delivery of insulin: preparation and characterization. Pharmazie 2001,56(3),217-219","journal-title":"Pharmazie"},{"key":"ref=136","first-page":"210","volume":"141","author":"Hosny E.A.","year":"2002","unstructured":"Hosny E.A.; Elkheshen S.A.; Saleh S.I.; Buccoadhesive tablets for insulin delivery: in vitro and in vivo studies. Boll Chim Farm 2002,141(3),210-217","journal-title":"Boll Chim Farm"},{"key":"ref=137","author":"Remon J.","year":"2005","unstructured":"Remon J.; Nasal delivery of peptides using powder carriers based on starch\/poly(acrylic acid). Thesis submitted to obtain the degree of Doctor in Pharmaceutical Sciences Ghent University 2005"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"E329","DOI":"10.1208\/pt060243","volume":"6","author":"Challa R.","year":"2005","unstructured":"Challa R.; Ahuja A.; Ali J.; Khar R.K.; Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech 2005,6(2),E329-E357","journal-title":"AAPS PharmSciTech"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0169-409X(98)00054-4","volume":"36","author":"Merkus F.W.","year":"1999","unstructured":"Merkus F.W.; Verhoef J.C.; Marttin E.; Romeijn S.G.; Hermens W.A.; Schipper N.G.; Schipper N.; Cyclodextrins in nasal drug delivery. Adv Drug Deliv Rev 1999,36(1),41-57","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1210\/endo.135.6.7988421","volume":"135","author":"Pillion D.J.","year":"1994","unstructured":"Pillion D.J.; Atchison J.A.; Gargiulo C.; Wang R.X.; Wang P.; Meezan E.; Insulin delivery in nosedrops: New formulations containing alkylglycosides. Endocrinology 1994,135(6),2386-2391","journal-title":"Endocrinology"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijpharm.2004.05.007","volume":"281","author":"Yu S.","year":"2004","unstructured":"Yu S.; Zhao Y.; Wu F.; Zhang X.; L&#xFC; W.; Zhang H.; Zhang Q.; Nasal insulin delivery in the chitosan solution: In vitro and in vivo studies. Int J Pharm 2004,281(1-2),11-23","journal-title":"Int J Pharm"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1002\/jps.20700","volume":"95","author":"Krauland A.H.","year":"2006","unstructured":"Krauland A.H.; Leitner V.M.; Grabovac V.; Bernkop-Schn&#xFC;rch A.; In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan. J Pharm Sci 2006,95(11),2463-2472","journal-title":"J Pharm Sci"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijpharm.2005.10.016","volume":"307","author":"Krauland A.H.","year":"2006","unstructured":"Krauland A.H.; Guggi D.; Bernkop-Schn&#xFC;rch A.; Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. Int J Pharm 2006,307(2),270-277","journal-title":"Int J Pharm"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2006.03.011","volume":"113","author":"Wang J.","year":"2006","unstructured":"Wang J.; Tabata Y.; Morimoto K.; Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats. J Control Release 2006,113(1),31-37","journal-title":"J Control Release"},{"key":"ref=145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpharm.2017.12.036","volume":"537","author":"Chun Y.","year":"2018","unstructured":"Chun Y.; Microparticles, microcapsules and microspheres: A review of recent developments and pro-spects for oral delivery of insulin. Int J Pharm 2018,537(1-2),223-244","journal-title":"Int J Pharm"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3109\/10717544.2012.746401","volume":"20","author":"Nema T.","year":"2013","unstructured":"Nema T.; Jain A.; Jain A.; Shilpi S.; Gulbake A.; Hurkat P.; Jain S.K.; Insulin delivery through nasal route using thiolated microspheres. Drug Deliv 2013,20(5),210-215","journal-title":"Drug Deliv"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1002\/jps.20123","volume":"93","author":"Arnold J.J.","year":"2004","unstructured":"Arnold J.J.; Ahsan F.; Meezan E.; Pillion D.J.; Correlation of tetradecylmaltoside induced increases in nasal peptide drug delivery with morphological changes in nasal epithelial cells. J Pharm Sci 2004,93(9),2205-2213","journal-title":"J Pharm Sci"},{"key":"ref=148","first-page":"603","volume":"2","author":"Pandey S.","year":"2010","unstructured":"Pandey S.; Non-Invasive Insulin Delivery Systems: Challenges and Needs for Improvement. Int J Pharm Tech Res 2010,2(1),603-614","journal-title":"Int J Pharm Tech Res"},{"key":"ref=149","first-page":"249","volume":"249","author":"Yamamoto A.","year":"1989","unstructured":"Yamamoto A.; Luo A.M.; Dodda-Kashi S.; Lee V.H.; The ocular route for systemic insulin delivery in the albino rabbit. J Pharmacol Exp Ther 1989,249(1),249-255","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=150","first-page":"1274","volume":"271","author":"Pillion D.J.","year":"1994","unstructured":"Pillion D.J.; Atchison J.A.; Wang R.X.; Meezan E.; Alkylglycosides enhance systemic absorption of insulin applied topically to the rat eye. J Pharmacol Exp Ther 1994,271(3),1274-1280","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1271\/bbb.70.1003","volume":"70","author":"Lee H.K.","year":"2006","unstructured":"Lee H.K.; Kwon J.H.; Park S.H.; Kim C.W.; Enhanced hypoglycemic activity following intratracheal administration of insulin microcrystal suspension with injection adjuvant. Biosci Biotechnol Biochem 2006,70(4),1003-1005","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0378-5173(01)00588-9","volume":"217","author":"Mitra R.","year":"2001","unstructured":"Mitra R.; Pezron I.; Li Y.; Mitra A.K.; Enhanced pulmonary delivery of insulin by lung lavage fluid and phospholipids. Int J Pharm 2001,217(1-2),25-31","journal-title":"Int J Pharm"},{"key":"ref=153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/17435889.3.1.1","volume":"3","author":"Smola M.","year":"2008","unstructured":"Smola M.; Vandamme T.; Sokolowski A.; Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int J Nanomedicine 2008,3(1),1-19","journal-title":"Int J Nanomedicine"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/02652040400000447","volume":"21","author":"Aguiar M.M.","year":"2004","unstructured":"Aguiar M.M.; Rodrigues J.M.; Silva Cunha A.; Encapsulation of insulin-cyclodextrin complex in PLGA microspheres: A new approach for prolonged pulmonary insulin delivery. J Microencapsul 2004,21(5),553-564","journal-title":"J Microencapsul"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jconrel.2006.03.014","volume":"113","author":"Huang Y.Y.","year":"2006","unstructured":"Huang Y.Y.; Wang C.H.; Pulmonary delivery of insulin by liposomal carriers. J Control Release 2006,113(1),9-14","journal-title":"J Control Release"},{"key":"ref=156","doi-asserted-by":"publisher","DOI":"10.1208\/ps050209","volume":"5","author":"Garcia-Contreras L.","year":"2003","unstructured":"Garcia-Contreras L.; Mor&#xE7;&#xF6;l T.; Bell S.J.; Hickey A.J.; Hickey A.; Evaluation of novel particles as pulmonary delivery systems for insulin in rats. AAPS PharmSci 2003,5(2)","journal-title":"AAPS PharmSci"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jconrel.2008.12.011","volume":"135","author":"Ungaro F.","year":"2009","unstructured":"Ungaro F.; d\u2019Emmanuele di Villa Bianca R.; Giovino C.; Miro A.; Sorrentino R.; Quaglia F.; La Rotonda M.I.; Insulin-loaded PLGA\/cyclodextrin large porous particles with improved aerosolization properties: In vivo deposition and hypoglycaemic activity after delivery to rat lungs. J Control Release 2009,135(1),25-34","journal-title":"J Control Release"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/bdd.702","volume":"31","author":"Hamishehkar H.","year":"2010","unstructured":"Hamishehkar H.; Emami J.; Najafabadi A.R.; Gilani K.; Minaiyan M.; Hassanzadeh K.; Mahdavi H.; Koohsoltani M.; Nokhodchi A.; Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats. Biopharm Drug Dispos 2010,31(2-3),189-201","journal-title":"Biopharm Drug Dispos"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0378-5173(01)00614-7","volume":"218","author":"Zhang Q.","year":"2001","unstructured":"Zhang Q.; Shen Z.; Nagai T.; Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int J Pharm 2001,218(1-2),75-80","journal-title":"Int J Pharm"},{"key":"ref=160","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0168-3659(97)00143-0","volume":"50","author":"Zakzewski C.A.","year":"1998","unstructured":"Zakzewski C.A.; Wasilewski J.; Cawley P.; Ford W.; Transdermal delivery of regular insulin to chronic diabetic rats: Effect of skin preparation and electrical enhancement. J Cont Release 1998,50(1-3),267-272","journal-title":"J Cont Release"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jconrel.2009.05.031","volume":"139","author":"Chen H.","year":"2009","unstructured":"Chen H.; Zhu H.; Zheng J.; Mou D.; Wan J.; Zhang J.; Shi T.; Zhao Y.; Xu H.; Yang X.; Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. J Control Release 2009,139(1),63-72","journal-title":"J Control Release"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"Prausnitz M.R.","year":"2008","unstructured":"Prausnitz M.R.; Langer R.; Transdermal drug delivery. Nat Biotechnol 2008,26(11),1261-1268","journal-title":"Nat Biotechnol"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jconrel.2012.05.030","volume":"161","author":"Liu S.","year":"2012","unstructured":"Liu S.; Jin M.N.; Quan Y.S.; Kamiyama F.; Katsumi H.; Sakane T.; Yamamoto A.; The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. J Control Release 2012,161(3),933-941","journal-title":"J Control Release"},{"key":"ref=164","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-3659(02)00054-8","volume":"81","author":"Alain Boucaud A.","year":"2012","unstructured":"Alain Boucaud A.; Garrigue M.A.; Machet L.; Vaillant L.; Patat F.; Effect of sonication parameters on transdermal delivery of insulin to hairless rat. J Control Release 2012,81(1\u20132),113-119","journal-title":"J Control Release"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jsps.2012.02.001","volume":"20","author":"Malakar J.","year":"2012","unstructured":"Malakar J.; Sen S.O.; Nayak A.K.; Sen K.K.; Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm J 2012,20(4),355-363","journal-title":"Saudi Pharm J"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0005-2736(02)00453-4","volume":"1564","author":"Sen A.","year":"2002","unstructured":"Sen A.; Daly M.E.; Hui S.W.; Transdermal insulin delivery using lipid enhance electroporation Biochimica et Biophysica Acta (BBA) \u2013. Biomembranes 2002,1564(1),5-8","journal-title":"Biomembranes"},{"key":"ref=167","volume":"8","author":"Ji-Won Y.","year":"2002","unstructured":"Ji-Won Y.; Hee-Sook J.; Recent advances in insulin gene therapy for type 1 diabetes. Trends Mol Med 2002,8(2)","journal-title":"Trends Mol Med"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.domaniend.2012.01.006","volume":"43","author":"Niessen S.J.","year":"2012","unstructured":"Niessen S.J.; Fernandez-Fuente M.; Mahmoud A.; Campbell S.C.; Aldibbiat A.; Huggins C.; Brown A.E.; Holder A.; Piercy R.J.; Catchpole B.; Shaw J.A.; Church D.B.; Novel diabetes mellitus treatment: mature canine insulin production by canine striated muscle through gene therapy. Domest Anim Endocrinol 2012,43(1),16-25","journal-title":"Domest Anim Endocrinol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cellimm.2006.06.004","volume":"240","author":"Soukhareva N.","year":"2006","unstructured":"Soukhareva N.; Jiang Y.; Scott D.W.; Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cells. Cell Immunol 2006,240(1),41-46","journal-title":"Cell Immunol"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejps.2011.10.029","volume":"45","author":"Jean M.","year":"2012","unstructured":"Jean M.; Alameh M.; De Jesus D.; Thibault M.; Lavertu M.; Darras V.; Nelea M.; Buschmann M.D.; Merzouki A.; Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes. Eur J Pharm Sci 2012,45(1-2),138-149","journal-title":"Eur J Pharm Sci"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.diabres.2005.08.005","volume":"71","author":"Oh T.K.","year":"2006","unstructured":"Oh T.K.; Li M.Z.; Kim S.T.; Gene therapy for diabetes mellitus in rats by intramuscular injection of lentivirus containing insulin gene. Diabetes Res Clin Pract 2006,71(3),233-240","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tem.2006.02.002","volume":"17","author":"Samson S.L.","year":"2006","unstructured":"Samson S.L.; Chan L.; Gene therapy for diabetes: Reinventing the islet. Trends Endocrinol Metab 2006,17(3),92-100","journal-title":"Trends Endocrinol Metab"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1582-4934.2004.tb00471.x","volume":"8","author":"Doss M.X.","year":"2004","unstructured":"Doss M.X.; Koehler C.I.; Gissel C.; Hescheler J.; Sachinidis A.; Embryonic stem cells: A promising tool for cell replacement therapy. J Cell Mol Med 2004,8(4),465-473","journal-title":"J Cell Mol Med"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1101\/gad.1303605","volume":"19","author":"Keller G.","year":"2005","unstructured":"Keller G.; Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005,19(10),1129-1155","journal-title":"Genes Dev"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1440-169X.2005.00814.x","volume":"47","author":"Kume S.","year":"2005","unstructured":"Kume S.; Stem-cell-based approaches for regenerative medicine. Dev Growth Differ 2005,47(6),393-402","journal-title":"Dev Growth Differ"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1007\/s00125-006-0434-x","volume":"49","author":"Serup P.","year":"2006","unstructured":"Serup P.; Embryonic stem cell-based diabetes therapy--a long road to travel. Diabetologia 2006,49(11),2537-2540","journal-title":"Diabetologia"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/08860229509037599","volume":"17","author":"Stratta R.J.","year":"1995","unstructured":"Stratta R.J.; Taylor R.J.; Larsen J.L.; Cushing K.; Pancreas transplantation. Ren Fail 1995,17(4),323-337","journal-title":"Ren Fail"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM200007273430401","volume":"343","author":"Shapiro A.M.","year":"2000","unstructured":"Shapiro A.M.; Lakey J.R.; Ryan E.A.; Korbutt G.S.; Toth E.; Warnock G.L.; Kneteman N.M.; Rajotte R.V.; Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000,343(4),230-238","journal-title":"N Engl J Med"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1758-5996-1-4","volume":"1","year":"2009","unstructured":"Stem cell transplantation for type-1 diabetes mellitus. Diabetes Metab Syndr 2009,1,4","journal-title":"Diabetes Metab Syndr"},{"key":"ref=180","first-page":"1","volume":"11","author":"Franco F.","year":"2011","unstructured":"Franco F.; Terumasa O.; Carla P.; Jenny G.; Chong Wee L.; Masaru A.; Anna D.; Stefano L.; Claudia P.; Roberto L.; Piero M.; Giorgio S.; Marc H.; Lucia P.; Rohit N.; Altered insulin receptor signaling and beta cell cycle dynamics in type 2 diabetes mellitus. PLoS One 2011,11,1-11","journal-title":"PLoS One"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"Butler A.E.","year":"2003","unstructured":"Butler A.E.; Janson J.; Bonner-Weir S.; Ritzel R.; Rizza R.A.; Butler P.C.; &#x3B2;-cell deficit and increased &#x3B2;-cell apoptosis in humans with type 2 diabetes. Diabetes 2003,52(1),102-110","journal-title":"Diabetes"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1463-1326.2008.00969.x","volume":"10","author":"Rahier J.","year":"2008","unstructured":"Rahier J.; Guiot Y.; Goebbels R.M.; Sempoux C.; Henquin J.C.; Pancreatic &#x3B2;-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008,10(4)(Suppl. 4),32-42","journal-title":"Diabetes Obes Metab"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00006676-200410000-00009","volume":"29","author":"Marques R.G.","year":"2004","unstructured":"Marques R.G.; Fontaine M.J.; Rogers J.; C-peptide: much more than a byproduct of insulin biosynthesis. Pancreas 2004,29(3),231-238","journal-title":"Pancreas"},{"key":"ref=184","first-page":"919","volume":"9","author":"Gary T.","year":"2009","unstructured":"Gary T.; Wing-Yee K.; Peter C.; Wing-Bun C.; Xilin Y.; Ronald C.; Alice P.; Risa O.; Chun-Yip Y.; Chun-Chung C.; Juliana C.; Effect of interaction between C peptide levels and insulin treatment on clinical outcomes among patients with type-2 diabetes mellitus. CMAJ 2009,9,919-926","journal-title":"CMAJ"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1517\/14712598.2010.532786","volume":"10","author":"Riedel M.J.","year":"2010","unstructured":"Riedel M.J.; Kieffer T.J.; Treatment of diabetes with glucagon-like peptide-1 gene therapy. Expert Opin Biol Ther 2010,10(12),1681-1692","journal-title":"Expert Opin Biol Ther"},{"key":"ref=186","first-page":"8","volume":"13","author":"Danny M.","year":"2009","unstructured":"Danny M.; Mike L.; Nanotechnology and the future of diabetes management. J Diabetes Nurs 2009,13,8","journal-title":"J Diabetes Nurs"},{"key":"ref=187","volume":"1","author":"Abhilash M.","year":"2010","unstructured":"Abhilash M.; Nanorobots. Int J Pharma Bio Sci 2010,1(1)","journal-title":"Int J Pharma Bio Sci"},{"key":"ref=188","unstructured":"BD Ultra-Fine\u2122 Nano: BD\u2019s Shortest http:\/\/www.multivu.com\/assets\/58104\/documents\/58104-About-BD-NanoTM-with-PentaPointTM-original.pdf","journal-title":"BD Ultra-Fine\u2122 Nano: BD\u2019s Shortest"},{"key":"ref=189","first-page":"38","volume":"59","author":"Baruah M.P.","year":"2011","unstructured":"Baruah M.P.; Insulin pens: the modern delivery devices. J Assoc Physicians India 2011,59(Suppl.),38-40","journal-title":"J Assoc Physicians India"},{"key":"ref=190","first-page":"1552","volume":"11","author":"Nitesh C.","year":"2010","unstructured":"Nitesh C.; Sanjeev C.; Vandana H.; Alka A.; Vijender S.; Recent Advances in Insulin Delivery Systems: An Update. World Appl Sci J 2010,11(12),1552-1556","journal-title":"World Appl Sci J"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1687-9856-2012-28","volume":"2012","author":"Ramchandani N.","year":"2012","unstructured":"Ramchandani N.; Heptulla R.A.; New technologies for diabetes: A review of the present and the future. Int J Pediatr Endocrinol 2012,2012(1),28","journal-title":"Int J Pediatr Endocrinol"},{"key":"ref=192","first-page":"120","volume":"10","author":"Marcus A.","year":"2008","unstructured":"Marcus A.; Diabetes care - insulin delivery in a changing world. Medscape J Med 2008,10(5),120","journal-title":"Medscape J Med"},{"key":"ref=193","first-page":"45","author":"Zeynep G.","year":"2020","unstructured":"Zeynep G.; Yujiao Z.; Mehrnaz A.; Shannon G.; Dayong W.; Zhaoyang F.; Shu W.; Recent advances in nano-encapsulation of phytochemicals to combat obesity and its comorbidities. J Agric Food Chem 2020,45","journal-title":"J Agric Food Chem"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/194237","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/194237\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/194237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T08:31:47Z","timestamp":1699173107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/194237\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":193,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557521666210623164052","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}